Projects / Programmes source: ARIS

Poskus izboljšanja zdravljenja malignih tumorjev, zmanjšanja posledic zdravljenja in proučevanje prognostičnih dejavnikov (Slovene)

Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   

Code Science Field
B007  Biomedical sciences  Medicine (human and vertebrates) 
B200  Biomedical sciences  Cytology, oncology, cancerology 
Head and neck carcinoma, hyperfractionation, hyperthermia, cathepsins, catepsins'' inhibitors- prognostic value, urokinase- type plasminogen activator, plasminogen activator inhibitor type 1, stereoradiosurgery
Evaluation (rules)
source: COBISS
Researchers (12)
no. Code Name and surname Research area Role Period No. of publicationsNo. of publications
1.  00702  PhD Marjan Budihna  Oncology  Head  1996 - 2001  125 
2.  13976  MSc Janez Burger  Oncology  Researcher  2000 - 2001  28 
3.  05315  Ladislava Furlan  Oncology  Researcher  1996 - 2001  20 
4.  09966  PhD Boris Jančar  Oncology  Researcher  1998 - 2001  95 
5.  09762  PhD Hotimir Lešničar  Oncology  Researcher  1998 - 2001  125 
6.  08750  PhD Zvonimir Rudolf  Oncology  Researcher  1998 - 2001  258 
7.  14576  PhD Primož Strojan  Oncology  Researcher  1996 - 2001  805 
8.  00712  PhD Janez Škrk  Oncology  Researcher  1998 - 2001  173 
9.  05316  PhD Erika Šoba-Podobnik  Oncology  Researcher  1998 - 2001  52 
10.  12198  Alenka Vodnik-Cerar  Oncology  Researcher  2000 - 2001  27 
11.  13156  PhD Lorna Zadravec Zaletel  Oncology  Researcher  1996 - 2001  250 
12.  07750  PhD Matjaž Zwitter  Oncology  Researcher  1998 - 2001  384 
Organisations (1)
no. Code Research organisation City Registration number No. of publicationsNo. of publications
1.  0302  Institute of Oncology Ljubljana  Ljubljana  5055733000  15,468 
In the study “An attempt to improve the treatment of malignant tumours, to moderate sequels of treatment and the study of some prognostic factors” we will try to improve the treatment results in some head and neck tumours, and in brain tumours with hyperfractionated irradiation. At the same time our wish is to reduce side effects of the irradiation treatment. We would like also to improve the irradiation technique of some malignant and nonmalignant brain lesions by introducing stereotactic radiosurgery. Using microwave hyperthermia in conjuction with irradiation, we hope to improve the results of irradiation treatment of some advanced, previously untreated or recurrent tumours. In the prolongation of the study we would like to improve the heating system in such a way that more customization of the heating regarding the size or depth of the tumour would be possible. In the continuation of the study of prognostic value of the tumour and serum concentration of the cathepsins B, D, H, L and their inhibitors stefins A and B, we would like to incorporate the plasminogen activator and its inhibitor as well as cystatin C.
Views history